Last reviewed · How we verify

NCT06626802

Steroid Versus Mitomycin-C Use in Pediatric Benign Recurrent Esophageal Stricture

Completed NA Last updated 4 October 2024
What this trial tests

NA trial testing Balloon Dilation + Topical Mitomycin in Esophageal Stricture in 24 participants. Completed in 30 June 2024.

Timeline
1 July 2023
Primary endpoint
30 June 2024
30 June 2024

Quick facts

Lead sponsorKing Edward Medical University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment24
Start date1 July 2023
Primary completion30 June 2024
Estimated completion30 June 2024
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

King Edward Medical University

Who can join

Under 16, any sex, with Esophageal Stricture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the efficacy of steroid injection versus topical mitomycin-C in the treatment of pediatric benign recurrent esophageal strictures. The rationale for this study is to compare the two therapeutic options in order to measure their effectiveness, in terms of improvement of Dysphagia Severity Score (DSS).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Esophageal Stricture

Currently open trials in the same condition.

Other King Edward Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06626802.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing